[1]魏耕树 朱恩林 王欣 王卓.益气宣痹汤治疗新冠肺炎后肺纤维化倾向可行性探讨[J].陕西中医药大学学报,2020,(预出版):036-40.
 Gengshu Wei,Enlin Zhu,Xin Wang,et al.Feasibility of Yiqi Xuanbi Decoctionin treating pulmonary fibro - sisafter new crown pneumonia[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(预出版):036-40.
点击复制

益气宣痹汤治疗新冠肺炎后肺纤维化倾向可行性探讨
分享到:

《陕西中医药大学学报》[ISSN:2096-1340/CN:61-1501/R]

卷:
期数:
2020年预出版
页码:
036-40
栏目:
出版日期:
2020-06-20

文章信息/Info

Title:
Feasibility of Yiqi Xuanbi Decoctionin treating pulmonary fibro - sisafter new crown pneumonia
作者:
魏耕树 朱恩林 王欣 王卓
陕西中医药大学附属医院,陕西咸阳712000
Author(s):
Gengshu Wei Enlin Zhu Xin Wang Zhuo Wang
Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang China, 712000
关键词:
新冠肺炎肺间质纤维化虚实夹杂益气宣痹汤
Keywords:
Novel coronavirus pneumonia Pulmonary fibrosis Deficiency and excess Yiqi Xuanbi Decoction
摘要:
随着新型冠状病毒肺炎符合出院标准的患者逐渐增多,出院后新冠肺炎后肺间质纤维化倾向的治疗应该引起重视,查阅文献,并分析新冠肺炎后肺纤维化倾向的临床特征及中医分型,发现恢复期患者病机为虚实夹杂,肺气不宣,其虚以肺脾气虚或气阴两虚为主,其实以痰瘀阻络为主?益气宣痹汤具有益气宣痹?活血通络作用,为临床治疗肺间质纤维化的经验方,建议对新冠肺炎后肺纤维化倾向患者给予治疗?
Abstract:
With novel coronavirus pneumonia meeting the discharge standard, patients gradually increase. After novel coronavirus pneumonia, the treatment of pulmonary fibrosis tends to be emphasized. Literature review, and novel coronavirus pneumonia after the analysis of the clinical characteristics and TCM classification of lung fibrosis. It was found that the patients in the recovery period were deficiency of lung qi and spleen or deficiency of both qi and Yin, Phlegm and blood stasis block collaterals, The pathogenesis of the disease is mixed with deficiency and excess, and the lung qi is not clear.

参考文献/References:

[1]刘清泉,夏文广,安长青,等.中西医结合治疗新型冠状病毒肺炎作用的思考[J/OL].中医杂志.http://kns.cnki.net/kcms/detail/11.2166.R.20200215.1057.002.html.
[2]郑文科,张俊华,杨丰文,等.中医药防治新型冠状病毒感染的肺炎各地诊疗方案综合分析[J/OL].中医杂志,2020.(2020-02-06)[2020-02-14].http://kns.cnki.net/Kcms/detail/11.2166.r.20200206.1113.002.html.
[3]王玉光,齐文升,马家驹,等.新型冠状病毒(2019-nCoV)肺炎中医临床特征与辨证治疗初探[J/OL].中医杂志.http://kns.cnki.net/kcms/detail/11.2166.R.20200129.1258.002.html
[4]苗青,丛晓东,王冰,王玉光,张忠德.新型冠状病毒感染的肺炎的中医认识与思考[J/OL].中医杂志.http://kns.cnki.net/kcms/detail/11.2166.R.20200205.1606.002.html
[5]钟飞扬,张寒菲,等,新型冠状病毒肺炎的CT影像学表现[J].武汉大学学报(医学版).http://kns.cnki.net/kcms/detail/42.1677.R.20200213.1408.001.html
[6] Zhou P, Yang X, Wang X, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin [J/OL] . Nature, 2020. Doi: 10. 1038/ s41586 - 020 -2012 -7.
[7]彭如臣,单锐,史英,等.SARS患者骨缺血性坏死的MRI检查[J].临床放射学杂志,2004,23(4):318-320.
[8] Mckee M D, Waddell J P , kuclo P A, et al. Oste onecrosis of the femoral head in men following short course cortic osteroid therapy: a report of 15 cases [ J] . CMA J,2001, 164: 205.
[9]杨淦,张先元,曹桅,等.特发性肺纤维化与肺痹?肺萎关系浅析[J].亚太传统医药,2015.11(2):52一53
[10]中华人民共和国中央人民政府.仝小林院士“解读”《新型冠状病毒感染的肺炎诊疗方案(试行第四版)》中的中医治疗方案[EB/OL].(2020-01-28)[2020-02-12].http://www.gov.cn/zhengce/2020-01/28/content_5472789.htm.
[11]范佳琳,张诗军.“因湿致瘀”理论研究进展[J].深圳中西医结合杂志,2008,10(5):317-320.
[12]袁洪霞,陈艳春.黄芪的现代药理研究及其临床应用[J].山东中医药大学学报,2000,9(5):397-399
[13]蔺兴遥,张毅,李娟,等.黄茂黄酮与红茂黄酮对肺间质纤维化模型大鼠肺功能影响的对比研究[J].中成药,2013,35(8):1770-1773..
[14]王慧,袁德培,曾楚华,陈壮.黄精的药理作用及临床应用研究进展[J].湖北民族学院学报(医学版),2017,34(2):58-60+64.
[15]周二付.地龙的现代药理及常见临床配伍分析[J].中国现代药物应用,2014,8(3):238-239.
[16]王秀华,刘爱东,徐彩云.鸡血藤抗血栓形成作用的研究[J].长春中医学院学报,2005,5(04):41.
[17]王薇.赤芍化学成分和药理作用的研究进展[J].黑龙江科技信息,2015(17):109.

相似文献/References:

[1]杨璞叶,黄小正,杨明博,等.从病理学角度探讨清肺排毒汤联合克力芝治疗新冠肺炎的优势[J].陕西中医药大学学报,2020,(预出版):024.
 Yang Puye,Huang Xiaozheng,Yang Mingbo,et al.Advantages of novel coronavirus pneumonia treated by Qingfei Detox Soup combined with Lopinavir and Ritonavir Tablets from the perspective of pathology[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(预出版):024.
[2]赵晓平 昝强 范小璇** 董盛 孙建飞 周振国 杨磊 岳黎明 王建丽 杨志霈.陕西中医药大学附属医院抗击新冠肺炎疫情“4+4”模式**[J].陕西中医药大学学报,2020,(预出版):061.
 Xiaoping Zhao,Qiang Zan,Xiaoxuan Fan*,et al.Follow the Pattern of 4+4 to Prevention and Control Novel Coronavirus Pneumonia(NCP) in Affiliated Hospital of Shaanxi University of Chinese Medicine[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(预出版):061.
[3]赵晓平 昝强 范小璇 董盛 孙建飞 周振国 杨磊 岳黎明 王建丽 杨志霈.陕西中医药大学附属医院抗击新冠肺炎疫情“4+4”模式[J].陕西中医药大学学报,2020,(02):008.[doi:10.13424/j.cnki.jsctcm.2020.02.003]
 Zhao Xiaoping,Zan Qiang,Fan Xiaoxuan,et al.The 4 +4 Pattern to Prevent and Control Coronavirus Disease 2019 in Affiliated Hospital of Shaanxi University of Chinese Medicine[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(预出版):008.[doi:10.13424/j.cnki.jsctcm.2020.02.003]
[4]杨璞叶 黄小正 杨明博 张鑫.从病理学角度探讨清肺排毒汤联合克力芝治疗新冠肺炎的优势[J].陕西中医药大学学报,2020,(03):001.[doi:10.13424/j.cnki.jsctcm.2020.03.001]
 Yang Puye,Huang Xiaozheng,Yang Mingbo,et al.Advantages of novel coronavirus pneumonia treated by Qingfei Detox Soup combined with Lopinavir and Ritonavir Tablets from the perspective of pathology[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(预出版):001.[doi:10.13424/j.cnki.jsctcm.2020.03.001]

备注/Memo

备注/Memo:
通讯作者:魏耕树,主任医师?E-mail:zhuenlin2013@163.com
更新日期/Last Update: 2020-03-19